BMRN
Price
$55.17
Change
+$1.07 (+1.98%)
Updated
Jun 27 closing price
Capitalization
10.58B
37 days until earnings call
ORYZF
Price
$3.22
Change
+$0.19 (+6.27%)
Updated
Jun 9 closing price
Capitalization
243.16M
Interact to see
Advertisement

BMRN vs ORYZF

Header iconBMRN vs ORYZF Comparison
Open Charts BMRN vs ORYZFBanner chart's image
BioMarin Pharmaceutical
Price$55.17
Change+$1.07 (+1.98%)
Volume$3.33M
Capitalization10.58B
Oryzon Genomics SA
Price$3.22
Change+$0.19 (+6.27%)
Volume$833
Capitalization243.16M
BMRN vs ORYZF Comparison Chart in %
Loading...
BMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORYZF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BMRN vs. ORYZF commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMRN is a Buy and ORYZF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (BMRN: $55.17 vs. ORYZF: $3.22)
Brand notoriety: BMRN and ORYZF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BMRN: 165% vs. ORYZF: 33%
Market capitalization -- BMRN: $10.58B vs. ORYZF: $243.16M
BMRN [@Biotechnology] is valued at $10.58B. ORYZF’s [@Biotechnology] market capitalization is $243.16M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMRN’s FA Score shows that 0 FA rating(s) are green whileORYZF’s FA Score has 0 green FA rating(s).

  • BMRN’s FA Score: 0 green, 5 red.
  • ORYZF’s FA Score: 0 green, 5 red.
According to our system of comparison, ORYZF is a better buy in the long-term than BMRN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMRN’s TA Score shows that 5 TA indicator(s) are bullish while ORYZF’s TA Score has 3 bullish TA indicator(s).

  • BMRN’s TA Score: 5 bullish, 2 bearish.
  • ORYZF’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, BMRN is a better buy in the short-term than ORYZF.

Price Growth

BMRN (@Biotechnology) experienced а +0.31% price change this week, while ORYZF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

BMRN is expected to report earnings on Aug 05, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BMRN($10.6B) has a higher market cap than ORYZF($243M). ORYZF YTD gains are higher at: 98.969 vs. BMRN (-16.066). BMRN has higher annual earnings (EBITDA): 777M vs. ORYZF (834K). BMRN has more cash in the bank: 1.27B vs. ORYZF (8.44M). BMRN has higher revenues than ORYZF: BMRN (2.95B) vs ORYZF (0).
BMRNORYZFBMRN / ORYZF
Capitalization10.6B243M4,362%
EBITDA777M834K93,165%
Gain YTD-16.06698.969-16%
P/E Ratio20.43N/A-
Revenue2.95B0-
Total Cash1.27B8.44M15,068%
Total Debt602MN/A-
FUNDAMENTALS RATINGS
BMRN: Fundamental Ratings
BMRN
OUTLOOK RATING
1..100
62
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
70
PRICE GROWTH RATING
1..100
84
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BMRNORYZF
RSI
ODDS (%)
Bullish Trend 3 days ago
72%
Bearish Trend 3 days ago
20%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
63%
Bullish Trend 3 days ago
40%
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
Bullish Trend 3 days ago
68%
Bearish Trend 3 days ago
29%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
55%
Bullish Trend 3 days ago
19%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
63%
Bullish Trend 3 days ago
17%
Advances
ODDS (%)
Bullish Trend 20 days ago
59%
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
64%
N/A
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
73%
N/A
Aroon
ODDS (%)
Bearish Trend 3 days ago
63%
Bearish Trend 3 days ago
6%
View a ticker or compare two or three
Interact to see
Advertisement
BMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORYZF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CLTAX15.910.14
+0.89%
Catalyst/Lyons Tactical Allocation A
FHEAX16.480.07
+0.43%
Fidelity Advisor Real Estate A
VSTCX39.300.15
+0.38%
Vanguard Strategic Small-Cap Equity Inv
JCVWX24.950.08
+0.32%
JHancock Classic Value R6
ACMVX15.770.02
+0.13%
American Century Mid Cap Value Inv

BMRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMRN has been loosely correlated with ITOS. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if BMRN jumps, then ITOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMRN
1D Price
Change %
BMRN100%
+1.98%
ITOS - BMRN
49%
Loosely correlated
-0.70%
IBO - BMRN
46%
Loosely correlated
-18.26%
IONS - BMRN
42%
Loosely correlated
N/A
TECH - BMRN
40%
Loosely correlated
-1.82%
KRYS - BMRN
40%
Loosely correlated
-2.60%
More

ORYZF and

Correlation & Price change

A.I.dvisor tells us that ORYZF and REPL have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ORYZF and REPL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORYZF
1D Price
Change %
ORYZF100%
N/A
REPL - ORYZF
30%
Poorly correlated
N/A
TVGN - ORYZF
24%
Poorly correlated
+5.08%
GNNSF - ORYZF
24%
Poorly correlated
N/A
IBIO - ORYZF
23%
Poorly correlated
N/A
BMRN - ORYZF
23%
Poorly correlated
+1.98%
More